Home › Tumor sa Utak
Pag-aaral pangklinika para sa Tumor sa Utak na nagre-recruit sa U.S.
199 pag-aaral para sa Tumor sa Utak ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX35 pag-aaral
- Boston, MA28 pag-aaral
- New York City, NY25 pag-aaral
- Washington, DC21 pag-aaral
- Los Angeles, CA16 pag-aaral
- Miami, FL15 pag-aaral
- Durham, NC14 pag-aaral
- St. Louis, MO12 pag-aaral
- Rochester, MN12 pag-aaral
- Seattle, WA11 pag-aaral
- Chicago, IL11 pag-aaral
- Columbus, OH11 pag-aaral
- Baltimore, MD11 pag-aaral
- Cleveland, OH11 pag-aaral
- Ann Arbor, MI10 pag-aaral
- Atlanta, GA9 pag-aaral
- Aurora, CO9 pag-aaral
- Detroit, MI9 pag-aaral
- Nashville, TN8 pag-aaral
- Minneapolis, MN8 pag-aaral
- Dallas, TX8 pag-aaral
- Arlington, VA8 pag-aaral
- San Francisco, CA8 pag-aaral
- Portland, OR8 pag-aaral
- Mountain View, CA7 pag-aaral
- Philadelphia, PA7 pag-aaral
- Cincinnati, OH7 pag-aaral
- San Diego, CA7 pag-aaral
- San Antonio, TX7 pag-aaral
- Baldwin Park, CA7 pag-aaral
- Jacksonville, FL7 pag-aaral
- Salt Lake City, UT7 pag-aaral
- Tampa, FL6 pag-aaral
- Birmingham, AL5 pag-aaral
- Milwaukee, WI5 pag-aaral
- Scottsdale, AZ5 pag-aaral
- Winston-Salem, NC5 pag-aaral
- Madison, WI5 pag-aaral
- New Rochelle, NY4 pag-aaral
- Memphis, TN4 pag-aaral
Ayos sa estado
- Alabama5 pag-aaral
- Arizona11 pag-aaral
- Arkansas3 pag-aaral
- California39 pag-aaral
- Colorado11 pag-aaral
- District of Columbia13 pag-aaral
- Florida29 pag-aaral
- Georgia12 pag-aaral
- Idaho3 pag-aaral
- Illinois14 pag-aaral
- Indiana4 pag-aaral
- Iowa4 pag-aaral
- Kansas3 pag-aaral
- Kentucky5 pag-aaral
- Maryland19 pag-aaral
- Massachusetts29 pag-aaral
- Michigan19 pag-aaral
- Minnesota19 pag-aaral
- Missouri13 pag-aaral
- Montana3 pag-aaral
- Nebraska5 pag-aaral
- New Hampshire4 pag-aaral
- New Jersey8 pag-aaral
- New York35 pag-aaral
- North Carolina20 pag-aaral
- Ohio23 pag-aaral
- Oklahoma3 pag-aaral
- Oregon8 pag-aaral
- Pennsylvania13 pag-aaral
- Rhode Island3 pag-aaral
- South Carolina5 pag-aaral
- Tennessee12 pag-aaral
- Texas42 pag-aaral
- Utah8 pag-aaral
- Virginia15 pag-aaral
- Washington12 pag-aaral
- Wisconsin11 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Evaluation and Treatment of Neurosurgical Disorders
Nagre-recruitObservasyonal na pag-aaral
Edad 4 hanggang 99 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT00060541Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Nagre-recruitPhase 1/2
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07416188Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07326566SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT04923542C-SMART vs BE Well for Patients With Brain Tumors
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07224503Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
Nagre-recruitPhase 1
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06389591Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05733312Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07248228Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07470606Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT04977375REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07831772Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis
Nagre-recruitMaagang Phase 1
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06055790Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07053033PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07827001A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05048212Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07227610A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07492680Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT05786924Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
Nagre-recruit
Edad 15 hanggang 120 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07374692A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04511013Development of MRF for Characterization of Brain Tumors After Radiotherapy
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06101069Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Nagre-recruitPhase 2
59 Months · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05535166OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07655583Home-based Vision Rehabilitation Guided by Brain Imaging
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07635329Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.